Not applicableApproved For MarketingNCT01160250
What this trial is testing
Vismodegib (GDC-0449) in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
Who this might be right for
Basal Cell Carcinoma
Genentech, Inc.
Showing 20 of 0 results